NPS Pharmaceuticals

by in

Entry	Author	Date	Location
Ironwood, NPS Pharma Tap Wall Street To Roll Out Lead Drugs	Ben Fidler	05/22/13	Boston
Fighting a Global War on Rare Diseases	Francois Nader	03/20/13	New York
Poll: Which of These 10 New Drugs Is Priced Too High?	Luke Timmerman	02/11/13	National
The Year In New York Biotech—Still Trying to Make It Here	Catherine Arnst	12/28/12	New York
NPS Wins First FDA Approval, for Short Bowel Syndrome Drug	Catherine Arnst	12/21/12	New York
East Coast Life Sciences Roundup: Orphan Drugs, Financings, More	Catherine Arnst	10/19/12	New York
Biotech Racking Up Successes Against Ultra-Orphan Diseases	Catherine Arnst	10/15/12	New York
NPS Rejiggers Amgen Deal, Sees $75M Extra Cash	Arlene Weintraub	07/02/12	New York
NPS Rallies as Good News Flows for Two Rare-Disease Drugs	Arlene Weintraub	06/25/12	New York
Lessons on Bouncing Back From Disaster	Francois Nader	12/08/11	New York
NPS Charts Positive Results on Parathyroid Drug	Arlene Weintraub	11/07/11	New York
NPS Pharma’s Not-So-Excellent Wall Street Adventure	Arlene Weintraub	11/03/11	New York
Xconomist of the Week: Tony Coles’ Journey from Mass General Doctor to SF Biotech CEO	Luke Timmerman	08/18/11	National
NPS Re-Jiggers Glaxo Partnership, Finds Value in Ultra-Orphan Diseases	Arlene Weintraub	08/09/11	New York
NPS Earns Seven-Figure Milestone Payment	Arlene Weintraub	03/28/11	New York
Page 1 of 1

Xconomy National